Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $24,223 | 7 | 96.6% |
| Food and Beverage | $854.17 | 18 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avazzia Inc. | $24,836 | 8 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $36.94 | 2 | $0 (2018) |
| Flexion Therapeutics, Inc. | $32.37 | 2 | $0 (2018) |
| Lilly USA, LLC | $31.84 | 2 | $0 (2018) |
| Allergan Inc. | $26.23 | 2 | $0 (2019) |
| Novo Nordisk Inc | $24.56 | 2 | $0 (2020) |
| GlaxoSmithKline, LLC. | $16.51 | 1 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $13.01 | 1 | $0 (2017) |
| Zimmer Biomet Holdings, Inc. | $12.98 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $11.92 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $48.34 | 4 | Novo Nordisk Inc ($24.56) |
| 2019 | $37.57 | 3 | Allergan Inc. ($26.23) |
| 2018 | $17,257 | 13 | Avazzia Inc. ($17,151) |
| 2017 | $7,734 | 5 | Avazzia Inc. ($7,685) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/16/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Obesity | ||||||
| 01/21/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Obesity | ||||||
| 12/05/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: Musculoskeletal | ||||||
| 10/25/2018 | Avazzia Inc. | — | Education | In-kind items and services | $8,409.42 | General |
| 08/30/2018 | Avazzia Inc. | — | Education | In-kind items and services | $255.00 | General |
| 08/16/2018 | Avazzia Inc. | — | Education | In-kind items and services | $1,331.91 | General |
| 07/20/2018 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology | ||||||
| 07/09/2018 | Avazzia Inc. | — | Education | In-kind items and services | $363.95 | General |
| 06/25/2018 | Avazzia Inc. | — | Education | In-kind items and services | $187.50 | General |
| 05/24/2018 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Neurology | ||||||
| 05/07/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Musculoskeletal | ||||||
| 04/27/2018 | Avazzia Inc. | — | Food and Beverage | Cash or cash equivalent | $613.38 | General |
| 04/26/2018 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Neurology | ||||||
| 04/12/2018 | Avazzia Inc. | — | Education | In-kind items and services | $5,990.00 | General |
| 01/31/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: VACCINES | ||||||
| 11/29/2017 | Avazzia Inc. | — | Education | Cash or cash equivalent | $7,684.95 | General |
| 08/28/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/05/2017 | Medtronic USA, Inc. | AQUAMANTYS (Device) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Advanced Energy Hemostatic Device | ||||||
| 06/02/2017 | Zimmer Biomet Holdings, Inc. | Unbranded Biologics (Device) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Sports Medicine | ||||||
| 04/24/2017 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 51 | 97 | $28,917 | $6,567 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 38 | $7,828 | $3,784 | 48.3% |
| 98927 | Osteopathic manipulative treatment, 5-6 body regions | Office | 2022 | 12 | 28 | $12,024 | $1,302 | 10.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,519 | $804.26 | 31.9% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2022 | 11 | 20 | $6,546 | $676.75 | 10.3% |
About Dr. Richard Dombroski, DO
Dr. Richard Dombroski, DO is a Family Medicine healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144209552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Dombroski, DO has received a total of $25,077 in payments from pharmaceutical and medical device companies, with $48.34 received in 2020. These payments were reported across 25 transactions from 13 companies. The most common payment nature is "Education" ($24,223).
As a Medicare-enrolled provider, Dombroski has provided services to 51 Medicare beneficiaries, totaling 97 services with total Medicare billing of $6,567. Data is available for 1 year (2022–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Sports Medicine, Neuromusculoskeletal Medicine & OMM
- Location Fort Worth, TX
- Active Since 01/13/2006
- Last Updated 08/18/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144209552
Products in Payments
- Dysport (Drug) $36.94
- Zilretta (Drug) $32.37
- VRAYLAR (Drug) $26.23
- Saxenda (Drug) $24.56
- TALTZ (Drug) $19.74
- BEXSERO (Biological) $16.51
- XIFAXAN (Drug) $13.01
- Unbranded Biologics (Device) $12.98
- TRADJENTA (Drug) $12.10
- FARXIGA (Drug) $11.92
- JANUVIA (Drug) $11.86
- INVOKANA (Drug) $11.34
- AQUAMANTYS (Device) $11.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fort Worth
Robert Campbell, D.o, D.O
Family Medicine — Payments: $354,620
Dr. Alex Guevara, D.o, D.O
Family Medicine — Payments: $75,300
Dr. Michael Carletti, D.o, D.O
Family Medicine — Payments: $48,058
Dr. Peter Damico, M.d, M.D
Family Medicine — Payments: $47,108
Randall Richwine, Do, DO
Family Medicine — Payments: $32,075
Dr. Kenton Murthy, D.o, M.s., M.p.h, D.O, M.S., M.P.H
Family Medicine — Payments: $18,859